NHMRC Clinical Trials Centre: Recent submissions
-
Adjuvant immunotherapy recommendations for stage III melanoma: physician and nurse interviews
Published 2021Background Adjuvant immunotherapy is revolutionising care for patients with resected stage III and IV melanoma. However, immunotherapy may be associated with toxicity, making treatment decisions complicated. This study ...Article -
Exploring the Integration of Environmental Impacts in the Cost Analysis of the Pilot MEL‑SELF Trial of Patient‑Led Melanoma Surveillance
Published 2022Aims Human health is intrinsically linked with planetary health. But planetary resources are currently being degraded and this poses an existential threat to human health and the sustainability of our healthcare systems. ...Article -
Approaches to prioritising research for clinical trial networks: a scoping review
Published 2022Background Prioritisation of clinical trials ensures that the research conducted meets the needs of stakeholders, makes the best use of resources and avoids duplication. The aim of this review was to identify and critically ...Article -
Developing an Australian Melanoma Clinical Outcomes Registry (MelCOR): a protocol paper
Published 2022Introduction Australia has the highest incidence of melanoma in the world with variable care provided by a diverse range of clinicians. Clinical quality registries aim to identify these variations in care and provide ...Article -
Incorporating carbon into health care: adding carbon emissions to health technology assessments
Published 2022Summary At the UN Climate Change Conference 26 in Glasgow, 50 countries committed to low-carbon health services, with 14 countries further committing to net-zero carbon health services by 2050. Reaching this target will ...Article